| Primary |
| Product Used For Unknown Indication |
40.0% |
| Angina Pectoris |
20.0% |
| Angina Unstable |
20.0% |
| Percutaneous Coronary Intervention |
20.0% |
|
| Hepatic Function Abnormal |
25.0% |
| Melaena |
25.0% |
| Rhabdomyolysis |
25.0% |
| Skin Discolouration |
25.0% |
|
| Secondary |
| Hypertension |
21.2% |
| Product Used For Unknown Indication |
8.1% |
| Prophylaxis |
6.6% |
| Anticoagulant Therapy |
6.1% |
| Anxiety |
6.1% |
| Coronary Artery Dilatation |
6.1% |
| Lipids Increased |
5.6% |
| Angina Pectoris |
5.1% |
| Depression |
5.1% |
| Cardiovascular Event Prophylaxis |
4.0% |
| Drug Use For Unknown Indication |
4.0% |
| Cardiac Failure |
3.5% |
| Hyperlipidaemia |
3.0% |
| Gastritis |
2.5% |
| Ill-defined Disorder |
2.5% |
| Interstitial Lung Disease |
2.5% |
| Antiplatelet Therapy |
2.0% |
| Diabetes Mellitus |
2.0% |
| Platelet Aggregation Inhibition |
2.0% |
| Type 2 Diabetes Mellitus |
2.0% |
|
| Hepatitis Acute |
37.5% |
| Shock |
15.6% |
| Feeling Cold |
6.3% |
| Acute Generalised Exanthematous Pustulosis |
3.1% |
| Cardiac Failure |
3.1% |
| Hyperkalaemia |
3.1% |
| Hypoglycaemia |
3.1% |
| Liver Disorder |
3.1% |
| Musculoskeletal Stiffness |
3.1% |
| Myocardial Infarction |
3.1% |
| Overdose |
3.1% |
| Portal Venous Gas |
3.1% |
| Restlessness |
3.1% |
| Thrombocytopenia |
3.1% |
| Urine Output Decreased |
3.1% |
| Vomiting |
3.1% |
|
| Concomitant |
| Hypertension |
18.1% |
| Product Used For Unknown Indication |
16.7% |
| Pain |
6.2% |
| Rheumatoid Arthritis |
6.1% |
| Diabetes Mellitus |
5.8% |
| Angina Pectoris |
5.7% |
| Prophylaxis |
4.3% |
| Atrial Fibrillation |
4.1% |
| Hyperlipidaemia |
3.8% |
| Pulmonary Arterial Hypertension |
3.5% |
| Constipation |
3.3% |
| Pneumonia |
3.3% |
| Drug Use For Unknown Indication |
3.1% |
| Insomnia |
2.6% |
| Cardiac Failure |
2.5% |
| Gastritis |
2.4% |
| Anaemia |
2.3% |
| Chronic Hepatitis C |
2.2% |
| Asthma |
2.0% |
| Hypertrophic Cardiomyopathy |
2.0% |
|
| Rhabdomyolysis |
13.1% |
| Infection |
9.8% |
| Renal Failure Acute |
9.0% |
| Pneumonia |
6.6% |
| Sepsis |
6.6% |
| Anaphylactic Shock |
4.9% |
| Interstitial Lung Disease |
4.9% |
| Myocardial Infarction |
4.9% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
4.9% |
| Hepatic Function Abnormal |
4.1% |
| Urinary Tract Infection |
4.1% |
| Cerebral Infarction |
3.3% |
| Rash |
3.3% |
| Stomatitis |
3.3% |
| Sudden Death |
3.3% |
| Vomiting |
3.3% |
| White Blood Cell Count Decreased |
3.3% |
| Anorexia |
2.5% |
| Drug Interaction |
2.5% |
| Fall |
2.5% |
|
| Interacting |
|
|
